Atlas Trials

12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients

Clinical trial NCT00159757 · TERMINATED

Trial details

NCT number
NCT00159757
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2003-11-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.